Tag: barriers

STAR4BBI Report on implementation for creation of new or revised standards

Posted on by LIFT-Team

Standards play a crucial role in supporting the growth of the bio-based products market. They can help to increase market transparency by providing common reference methods and requirements that enable the verification of claims and certification regarding the bio-based content, biodegradability or environmental sustainability of different products. However, inadequate standards can also act as barriers for certain products. So, what are the current EU standards or other related issues that hamper the growth of bio-based products? STAR4BBI (“Developing standards for bio-based industries”) analysed these barriers and proposed actions towards overcoming these.

The STAR4BBI Report on implementation for creation of new or revised standards (D4.3) aims to identify standards or other initiatives that hamper the growth of bio-based producers in the market. The goal is to remove these identified and shortlisted barriers preferably before the end of the project. The main barriers include:

  • Non-functional specifications
  • Biodegradability
  • Compostability
  • Multiple certificates in the market
  • Double testing

 

 

STAR4BBI Market entry barriers report

Posted on by LIFT-Team

Standards play a crucial role in supporting the growth of the bio-based products market. They can help to increase market transparency by providing common reference methods and requirements that enable the verification of claims and certification regarding the bio-based content, biodegradability or environmental sustainability of different products. However, inadequate standards can also act as barriers for certain products. So, what are the current EU standards or other related issues that hamper the growth of bio-based products? STAR4BBI (“Developing standards for bio-based industries”) analysed these barriers and proposed actions towards overcoming these.

The STAR4BBI market entry barriers report (D2.1) describes the market entry barriers due to regulation and standardisation that companies operating in the bio-based economy experience. The analysis is based on extensive interviews. Five main hurdles that were identified and are in detail discussed in the report are:

  • End of Life
  • Certification and Standards
  • Biofuel Policy
  • Long Term Policy
  • Communication and Image

BIO-TIC Pragmatic recommendations for action

Posted on by LIFT-Team

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

Principal barrier to European industrial biotechnology development was cost-competitiveness, both compared to fossil alternatives and compared to other regions of the world. This was affected by many factors including the cost of feedstock, technology readiness levels, and the market support for bio-based products. The cost competitiveness issue was compounded by difficulties in accessing finance for large scale projects, an often low end user awareness of IB derived products and by a lack of skills and operational alliances to drive the sector forward.

This press release discusses ten pragmatic recommendations for action to tackle identified barriers and hurdles, and to ensure that most of the market potential is realised in Europe. These cover feedstock issues (improve the opportunities for feedstock producers within the bioeconomy, investigate the scope for using novel biomass), processing issues (promote the use of co-products from processing, improve the bioconversion and downstream processing steps, identify, leverage and build upon EU capabilities for pilot and demonstration facilities), investment challenges (introduce a long-term, stable and transparent policy and incentive framework to promote the bioeconomy, and improve access to finance for large-scale projects) and support for innovation more generally (develop the skills needed now and in the future for the IB industry, assess and improve public perception and awareness of IB and bio-based products, develop stronger relationships between conventional and non-conventional players).

BIO-TIC Summary of hurdles and solutions in industrial biotechnology

Posted on by LIFT-Team

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

This document provides a concise overview of main hurdles and solutions collected during the multi-stakeholders iterative process. Presented solutions are discussed in more depth within either the BIO-TIC R&D roadmap or the BIO-TIC non-technological roadmap.

BIO-TIC Non-technological roadmap

Posted on by LIFT-Team

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

The non-technological roadmap identifies regulatory and non-technological hurdles that may prevent IB innovation from taking advantage of market opportunities., and proposes solutions for key market entry barriers.

RoadToBio – Roadmap for the Chemical Industry in Europe towards a Bioeconomy – Action Plan

Posted on by LIFT-Team

The Action Plan is the first entry point to the RoadToBio roadmap written for the chemical industry. It provides an overview of the key points of the roadmap and shows all identified barriers and recommended actions identified in the project for nine product groups  in which bio-based value chains already make up for a significant share, but can still be strengthened: adhesives, agrochemicals, cosmetics, lubricants, man-made fibres, paints and coatings,  plastics and/or polymers, solvents, and surfactants.

For these product groups the action plan provides:

  • description of current state and opportunities for bio-based products
  • overview scheme identifying drivers and barriers
  • chevron diagram showing the recommended actions for each barrier

For some wider issues that concern the chemical industry in the bioeconomy. referred to as general barriers, an overview is given and some recommended actions to overcome them are presented.